Abstract

Prognostic markers such as cerb-2, P53, nm23 and TGF-beta will be studied by immunohistochemistry and in situ hybridization in order to determine their role in prognosis of young women with breast cancer.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01CB009381-01
Application #
3774428
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost

  Institution

Name
Division of Cancer Biology and Diagnosis
Department
Type
DUNS #
City
State
Country
United States
Zip Code